Exelixis, Inc. (EXEL) - Earnings & Price History

EXEL: Exelixis, Inc. - 26.79, $7.87B, -0.21 (-0.78%)

Sector: Healthcare - Industry: Biotechnology

Exelixis, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of new medicines with the potential to enhance care and outcomes for people with cancer. It focuses on advancing cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, and VEGF receptors, which has shown clinical anti-tumor activity in approximately 20 forms of cancer and is the subject of a broad clinical development program. The company has received regulatory approval for two separate formulations of cabozantinib for the treatment of certain forms of kidney and thyroid cancer and marketed as CABOMETYX tablets in the United States and COMETRIQ capsules in the United States and European Union respectively. It also offers COTELLIC (cobimetinib), a selective inhibitor of MEK, in the United States and European Union; and is being evaluated for further potential in

Past EXEL reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-27AMC-0.0121.5323.0921.721.2522.53-6.02%-0.78%-6.76%9.15M
2016-11-03AMC-0.1311.9110.210.910.6511.916.86%9.27%16.76%11.29M
2016-08-03AMC-0.2711.079.3910.0310.0211.666.82%▲10.37%17.89%22.29M
2016-05-04AMC-0.254.694.334.294.254.77-0.92%9.32%8.31%6.23M
2016-02-29AMC-0.223.833.644.233.774.2516.21%-9.46%5.22%17.20M
2015-11-10AMC-0.25.746.336.055.686.1-4.42%-5.12%-9.32%6.84M
2015-08-11AMC-0.215.855.725.665.465.93-1.05%▲3.36%2.27%6.16M
2015-04-30AMC-0.242.832.572.772.722.937.78%2.17%10.12%4.76M
2015-02-24AMC-0.32.692.692.52.52.75-7.06%7.60%5.29M
2014-11-04AMCExelixis Inc-0.37-0.31.71.651.721.671.834.24%-1.16%3.03%5.68M
2014-07-31AMCExelixis Inc-0.39-0.384.194.034.123.984.262.23%▲1.70%3.97%5.25M
2014-05-01AMCExelixis Inc-0.36-0.393.323.523.53.213.51-0.57%-5.14%-5.68%5.80M
2014-02-20AMCExelixis Inc-0.387.027.166.966.387.13-2.79%0.86%-1.96%5.25M
2013-10-30AMCExelixis Inc-0.38-0.364.935.085.114.795.110.59%-3.52%-2.95%3.03M
2013-08-06AMCExelixis Inc-0.3-0.344.985.115.074.715.2-0.78%▲-1.78%-2.54%3.65M
2013-05-07AMC-0.284.934.594.674.654.941.74%5.57%7.41%1.43M
2013-02-21AMC-0.244.414.654.544.44.56-2.37%-2.86%-5.16%3.51M
2012-11-07AMC-0.34.584.714.714.53984.8-2.76%-2.76%4.95M
2012-08-02AMCQ2 2012 Exelixis, In-0.27-0.255.585.925.95.575.99-0.34%▲-5.42%-5.74%2.93M
2012-05-03AMCQ1 2012 Exelixis, In-0.17-0.184.524.584.514.374.63-1.53%0.22%-1.31%2.34M
2012-02-08AMCQ4 2011 Exelixis Inc-0.110.355.676.146.225.636.251.30%-8.84%-7.65%2.67M
2011-10-27AMCQ3 2011 Exelixis Inc0.560.597.67.817.737.437.84-1.02%-1.68%-2.69%1.67M
2011-08-04AMCQ2 2011 Exelixis Inc-0.17-0.166.746.8176.127.082.79%▲-3.71%-1.03%2.11M
2011-05-03AMCQ1 2011 Exelixis Ear-0.19-0.2411.1211.5711.5511.0611.66-0.17%-3.72%-3.89%2.48M
2011-02-22AMCQ4 2010 Exelixis Ear-0.21-0.1611.5210.5510.5110.412-0.38%9.61%9.19%7.22M
2010-11-04AMCQ3 2010 Exelixis Ear-0.06-0.084.364.454.34.34.55-3.37%1.40%-2.02%792.90K
2010-08-05AMCQ2 2010 Exelixis Ear-0.213.093.123.073.073.22-1.60%▲0.65%-0.96%547.80K
2010-05-11AMCQ1 2010 Exelixis Ear-0.31-0.46.275.335.745.576.287.69%9.23%17.64%4.10M
2010-03-09BMOQ4 2009 Exelixis Ear-0.276.316.816.826.226.860.15%-7.48%-7.34%2.06M
2009-10-29AMCQ3 2009 Exelixis Ear-0.32-0.246.085.715.715.656.356.48%6.48%2.25M
2009-07-30AMCQ2 2009 Exelixis Ear-0.41-0.425.355.95.845.315.84-1.02%▲-8.39%-9.32%2.14M
2009-05-07AMCQ1 2009 Exelixis Ear-0.33-0.344.794.594.74.664.922.40%1.91%4.36%991.00K
2009-03-04AMCQ4 2008 Exelixis Ear-0.35-0.364.334.634.54.324.69-2.81%-3.78%-6.48%1.15M
2008-10-27AMCQ3 2008 Exelixis Ear-0.41-0.363.013.033.162.933.24.29%-4.75%-0.66%2.52M
2008-08-05AMCQ2 2008 Exelixis Ear-0.41-0.435.977.116.535.76.58-8.16%▲-8.58%-16.03%4.47M
2008-05-06AMCQ1 2008 Exelixis Ear-0.38-0.396.97.817.736.767.76-1.02%-10.74%-11.65%2.29M
2008-02-14AMCQ4 2007 Exelixis Ear-0.29-0.196.766.756.776.76.980.30%-0.15%0.15%1.80M
2007-11-05AMCQ3 2007 Exelixis Ear-0.2-0.149.6210.2310.139.3510.25-0.98%-5.03%-5.96%2.35M
2007-08-07AMCQ2 2007 Exelixis Ear-0.28-0.2911.1710.2110.2310.1411.50.20%▲9.19%9.40%2.35M
2007-05-03AMCQ1 2007 Exelixis Ear-0.27-0.2511.810.8611.1111.0411.82.30%6.21%8.66%1.66M
2007-02-13AMCFourth Quarter and F-0.25-0.2710.7810.9410.8710.7110.92-0.64%-0.83%-1.46%915.20K
2006-11-02Q3 2006 Exelixis Ear-0.31-0.38.568.218.28.038.58-0.12%4.39%4.26%1.28M
2006-08-08AMCQ2 2006 Exelixis Ear-0.3-0.297.958.638.657.918.70.23%▲-8.09%-7.88%815.30K
2006-05-09Q1 2006 Exelixis Ear-0.29-0.3210.8711.2111.3210.6611.320.98%-3.98%-3.03%473.60K
2006-02-21Q4 and Year-End 2005-0.28-0.2910.139.859.89.810.27-0.51%3.37%2.84%686.00K
2005-11-03AMCQ3 2005 Exelixis Ear-0.39-0.288.57.98.038.038.51.65%5.85%7.59%403.70K
2005-08-08AMCQ2 2005 Exelixis Ear-0.05-0.138.328.588.527.898.56-0.70%▲-2.35%-3.03%866.80K
2005-05-09AMCQ1 2005 Exelixis Ear-0.367.987.588.347.698.5710.03%-4.32%5.28%1.39M
2005-02-16AMCQ4 2004 Exelixis Ear7.0377.16.957.261.43%-0.99%0.43%389.50K
2004-11-08AMCQ3 2004 Exelixis Ear8.928.938.948.849.240.11%-0.22%-0.11%528.40K
2004-08-05Q2 2004 Exelixis Ear6.567.167.166.397.2-8.38%-8.38%651.50K
2004-05-04AMCQ1 2004 Exelixis Ear109.869.679.6510.2-1.93%3.41%1.42%413.90K
2004-02-17Q4 2003 Exelixis Ear8.588.328.478.368.861.80%1.30%3.13%711.80K
2003-11-05Q3 2003 Exelixis Ear7.427.387.387.117.430.54%0.54%280.50K
2003-08-06AMCQ2 2003 Exelixis Ear6.346.816.86.197-0.15%▲-6.76%-6.90%565.30K
2003-05-07AMCQ1 2003 Exelixis Ear7.758.338.337.758.39-6.96%-6.96%251.70K
2003-02-19AMCQ4 2002 Exelixis Ear5.385.485.595.265.662.01%-3.76%-1.82%88.10K
2002-11-07AMCQ3 2002 Exelixis Ear5.95.795.855.76.091.04%0.85%1.90%456.30K
2002-08-06AMCQ2 2002 Exelixis Ear5.035.485.34.735.48-3.28%▲-5.09%-8.21%342.30K
2002-05-06AMCQ1 2002 Exelixis Ear6.568.918.156.538.16-8.53%-19.51%-26.37%769.70K
2002-03-20AMCQ4 2001 Exelixis Ear14.4813.7514.3113.5414.754.07%1.19%5.31%707.10K
2001-11-13AMCQ3 2001 Exelixis Ear14.915.21514.6515.16-1.32%-0.67%-1.97%373.50K
2001-08-08AMCQ2 2001 Exelixis Ear15.8415.8616.0515.4616.381.20%▲-1.31%-0.13%405.40K
2001-05-14AMCExelixis Q1 Earnings14.814.814.861414.860.41%-0.40%117.20K
2001-02-28AMCQ4 2000 Exelixis Ear9.8810.7510.259.7510.5-4.65%-3.61%-8.09%131.80K
2000-11-08AMCQ3 2000 Exelixis Ear24.8125.3825.523.1425.690.47%-2.71%-2.25%104.00K
2000-08-08AMCQ2 2000 Exelixis Ear41.7544.124237.7542.69-4.81%▲-0.60%-5.37%56.40K

Login | Register
Thursday Aug 24, 2017   EST
Enter a Ticker:

Economic Calendar

MBA Mortgage Applications 7:00 AM ET PMI Composite Flash 9:45 AM ET New Home Sales 10:00 AM ET EIA Petroleum Status Report 10:30 AM ET 2-Yr FRN Note Auction 11:30 AM ET Robert Kaplan Speaks 1:05 PM ET  

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY244.56-0.88-0.36%49,996,850

Upgrades/Downgrades